Are metformin-based combination approaches beneficial for non-small cell lung cancer: evidence from experimental and clinical studies
{{output}}
Despite having multiple treatment options, the overall outcomes, including the survival rates of non-small cell lung cancer (NSCLC) patients, remain relatively low, indicating the need to explore new approaches to achieve improved therapeutic responses. To tha... ...